241
Views
12
CrossRef citations to date
0
Altmetric
Reviews

Investigational cell cycle inhibitors in clinical trials for bladder cancer

, &
Pages 369-377 | Published online: 21 Dec 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Cheol Park, Jin-Woo Jeong, Min Ho Han, Hyesook Lee, Gi-Young Kim, Soojung Jin, Jung-Ha Park, Hyun Ju Kwon, Byung Woo Kim & Yung Hyun Choi. (2021) The anti-cancer effect of betulinic acid in u937 human leukemia cells is mediated through ROS-dependent cell cycle arrest and apoptosis. Animal Cells and Systems 25:2, pages 119-127.
Read now

Articles from other publishers (11)

Zhiyong Tan, Xiaorong Chen, Jieming Zuo, Shi Fu, Haifeng Wang & Jiansong Wang. (2023) Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model. Journal of Translational Medicine 21:1.
Crossref
So Young Kim, Hyun Hwangbo, Min Yeong Kim, Seon Yeong Ji, Da Hye Kim, Hyesook Lee, Gi-Young Kim, Sung-Kwon Moon, Sun-Hee Leem, Seok Joong Yun, Wun-Jae Kim, JaeHun Cheong, Cheol Park & Yung Hyun Choi. (2021) Betulinic Acid Restricts Human Bladder Cancer Cell Proliferation In Vitro by Inducing Caspase-Dependent Cell Death and Cell Cycle Arrest, and Decreasing Metastatic Potential. Molecules 26:5, pages 1381.
Crossref
Tiansong Yang, Qingyong Wang, Yuanyuan Qu, Yan Liu, Chuwen Feng, Yulin Wang, Weibo Sun, Zhongren Sun & Yulan Zhu. (2021) Punicalin Alleviates OGD/R-Triggered Cell Injury via TGF-β-Mediated Oxidative Stress and Cell Cycle in Neuroblastoma Cells SH-SY5Y. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-11.
Crossref
Jun-Hui Song, Juhee Park, Sung Lyea Park, Byungdoo Hwang, Wun-Jae Kim, Chan Lee & Sung-Kwon Moon. (2021) A Novel Cyclic Pentadepsipeptide, N-Methylsansalvamide, Suppresses Angiogenic Responses and Exhibits Antitumor Efficacy against Bladder Cancer. Cancers 13:2, pages 191.
Crossref
Qiushuang Wu, Janet P. C. Wong & Hang Fai Kwok. (2020) Putting the Brakes on Tumorigenesis with Natural Products of Plant Origin: Insights into the Molecular Mechanisms of Actions and Immune Targets for Bladder Cancer Treatment. Cells 9:5, pages 1213.
Crossref
Lu Wang, Song Chen, Yongwen Luo, Lushun Yuan, Tianchen Peng, Kaiyu Qian, Xuefeng Liu, Yu Xiao & Xinghuan Wang. (2019) Identification of several cell cycle relevant genes highly correlated with the progression and prognosis of human bladder urothelial tumor. Journal of Cellular Physiology 234:8, pages 13439-13451.
Crossref
Shutong Fan, Zumu Liang, Zhiqin Gao, Zhiwei Pan, Shaojie Han, Xiaoying Liu, Chunling Zhao, Weiwei Yang, Zhifang Pan & Weiguo Feng. (2018) Identification of the key genes and pathways in prostate cancer. Oncology Letters.
Crossref
Chiung-Yao Fang, Jeng-Sheng Chen, Shun-Kai Chang & Cheng-Huang Shen. (2018) Reversine induces autophagic cell death through the AMP-activated protein kinase pathway in urothelial carcinoma cells. Anti-Cancer Drugs 29:1, pages 29-39.
Crossref
Jorge M. Alves-Silva, Abderrahmane Romane, Thomas Efferth & Lígia Salgueiro. (2017) North African Medicinal Plants Traditionally Used in Cancer Therapy. Frontiers in Pharmacology 8.
Crossref
Chenghe Wang, Qiangqiang Ge, Zhong Chen, Jia Hu, Fan Li, Xiaodong Song, Hua Xu & Zhangqun Ye. (2015) A New Double Stranded RNA Suppresses Bladder Cancer Development by Upregulating p21 Waf1/CIP1 Expression . BioMed Research International 2015, pages 1-13.
Crossref
Sung Park, Se Won, Jun-Hui Song, Wun-Jae Kim & Sung-Kwon Moon. (2014) EPO gene expression induces the proliferation, migration�and invasion of bladder cancer cells through the p21WAF1‑mediated ERK1/2/NF-κB/MMP-9 pathway. Oncology Reports.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.